Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Short term Debt (2016 - 2021)

International Stem Cell (ISCO) has disclosed Short term Debt for 10 consecutive years, with $219000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Short term Debt changed N/A to $219000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $219000.0, a N/A change, with the full-year FY2020 number at $141000.0, changed N/A from a year prior.
  • Short term Debt was $219000.0 for Q1 2021 at International Stem Cell, up from $141000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.8 million in Q3 2017 to a low of $57000.0 in Q3 2020.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2017 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: surged 10476.92% in 2017, then plummeted 96.92% in 2020.
  • International Stem Cell's Short term Debt stood at $2.8 million in 2017, then crashed by 36.55% to $1.7 million in 2018, then grew by 5.9% to $1.8 million in 2019, then crashed by 92.37% to $141000.0 in 2020, then surged by 55.32% to $219000.0 in 2021.
  • Per Business Quant, the three most recent readings for ISCO's Short term Debt are $219000.0 (Q1 2021), $141000.0 (Q4 2020), and $57000.0 (Q3 2020).